Parvovirus B19 by Quantitative PCR
Also known as: PARV QNT
Use
This test is used to diagnose and monitor human parvovirus infection in patients with a suppressed or delayed immune response. It quantitatively measures the viral load of Parvovirus B19 using PCR to assist in clinical management and evaluation of the viral infection.
Special Instructions
Not provided.
Limitations
The test has a quantitative range of 2.0-8.0 log IU/mL (100-100,000,000 IU/mL). A negative result does not rule out the presence of PCR inhibitors or Parvovirus DNA concentrations below the detectable level. Inhibition may lead to underestimation of viral quantitation.
New York Approved
Methodology
PCR-based (qPCR)
Biomarkers
Parvovirus B19
Microorganism
LOINC Codes
- 74419-3 - B19V DNA SerPl NAA+probe-Log IU
- 48767-8 - Annotation comment Imp
- 74420-1 - B19V DNA SerPl NAA+probe-aCnc
- 31208-2 - Specimen source
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.5 mL
Container
Sterile container
Collection Instructions
Separate serum or plasma from cells. Transfer to a sterile container.
Causes for Rejection
Heparinized specimens
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 5 days |
| Frozen | 6 months |
Other tests from different labs that may be relevant